Nautilus Biotechnology, Inc.

NasdaqGS:NAUT Stock Report

Market Cap: US$90.1m

Nautilus Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:NAUT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Mar 25BuyUS$23,890Sujal PatelIndividual23,933US$1.00

Insider Trading Volume

Insider Buying: NAUT insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NAUT?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,457,0551.16%
General Public21,702,59017.2%
Institutions24,928,00619.8%
VC/PE Firms37,421,11329.7%
Individual Insiders40,639,70532.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 80.54% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16.4%
Parag Mallick
20,679,892US$14.8m0%no data
14%
Andreessen Horowitz LLC
17,653,917US$12.6m0%0.17%
13.7%
Sujal Patel
17,236,232US$12.3m0.45%no data
9.98%
Perceptive Advisors LLC
12,594,211US$9.0m0%0.29%
5.69%
Cercano Management LLC
7,172,985US$5.1m0%0.13%
4.77%
Madrona Venture Group
6,020,770US$4.3m0%13.04%
2.22%
BlackRock, Inc.
2,798,663US$2.0m-8.8%no data
2.2%
The Vanguard Group, Inc.
2,778,449US$2.0m0.44%no data
1.75%
Comprehensive Financial Management LLC
2,207,619US$1.6m0%0.04%
1.5%
Farzad Nazem
1,888,146US$1.3m0%no data
1.39%
Bain Capital Life Sciences Investors, LLC
1,759,000US$1.3m-12.1%0.19%
1.16%
Amazon.com, Inc.
1,457,055US$1.0m0%no data
0.91%
Geode Capital Management, LLC
1,142,542US$816.3k0.62%no data
0.74%
State Street Global Advisors, Inc.
930,531US$664.9k-0.26%no data
0.69%
The Clarius Group, LLC
866,586US$619.2k36.1%0.04%
0.61%
Dimensional Fund Advisors LP
770,353US$550.4k11.3%no data
0.58%
Tikvah Management LLC
726,895US$519.4k0%0.17%
0.48%
Botty Investors LLC
606,133US$433.1k-1.32%0.14%
0.38%
Northern Trust Global Investments
474,821US$339.3k-6.44%no data
0.36%
Matthew McIlwain
459,075US$328.0k0%no data
0.26%
Wexford Capital LP
325,239US$232.4k42.4%0.04%
0.22%
Sentinel Trust Co LBA
280,000US$200.1k9.8%0.02%
0.21%
Eaton Vance Management
262,696US$187.7k0%no data
0.2%
Alyeska Investment Group, L.P.
253,468US$181.1k-42.5%no data
0.2%
Renaissance Technologies LLC
250,221US$178.8k61.8%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/09 05:18
End of Day Share Price 2025/05/09 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nautilus Biotechnology, Inc. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew SykesGoldman Sachs
Subhalaxmi NambiGuggenheim Securities, LLC
Brandon CouillardJefferies LLC